9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+))

C167H112N16O4Pt4S — CID 161134093

About 9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+))

9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+)) (PubChem CID 161134093) has the molecular formula C167H112N16O4Pt4S and a molecular weight of 3219.22 g/mol. Its IUPAC name is 9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+)).

Molecular Properties

• Compound Name: 9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+))
• PubChem CID: 161134093
• Molecular Formula: C167H112N16O4Pt4S
• Molecular Weight: 3219.22 g/mol
• Exact Mass: 3216.74
• IUPAC Name: 9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+))
• SMILES: Cc1cccc(C)c1-c1cc(Oc2[c-]c(C3(c4ccccn4)c4ccccc4N(c4ccccc4)c4ccccc43)ccc2)[c-]c(-n2cccn2)c1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[c-]1c(Oc2[c-]c(C3(c4ccccn4)c4ccccc4N(c4ccccc4)c4ccccc43)ccc2)cccc1-c1nc2ccccc2s1.[c-]1c(Oc2[c-]c(C3(c4ccccn4)c4ccccc4N(c4ccccc4)c4ccccc43)ccc2)cccc1-n1cccn1.[c-]1c(Oc2[c-]c(C3(c4ccccn4)c4ccccc4N(c4ccccc4)c4ccccc43)ccc2)cccc1-n1nccn1
• InChI: InChI=1S/C47H34N4O.C43H27N3OS.C39H26N4O.C38H25N5O.4Pt/c1-33-15-12-16-34(2)46(33)35-29-38(50-28-14-27-49-50)32-40(30-35)52-39-20-13-17-36(31-39)47(45-25-10-11-26-48-45)41-21-6-8-23-43(41)51(37-18-4-3-5-19-37)44-24-9-7-22-42(44)47;1-2-16-32(17-3-1)46-38-23-7-4-20-35(38)43(41-26-10-11-27-44-41,36-21-5-8-24-39(36)46)31-15-13-19-34(29-31)47-33-18-12-14-30(28-33)42-45-37-22-6-9-25-40(37)48-42;1-2-14-30(15-3-1)43-36-21-6-4-19-34(36)39(38-23-8-9-24-40-38,35-20-5-7-22-37(35)43)29-13-10-17-32(27-29)44-33-18-11-16-31(28-33)42-26-12-25-41-42;1-2-13-29(14-3-1)42-35-20-6-4-18-33(35)38(37-22-8-9-23-39-37,34-19-5-7-21-36(34)42)28-12-10-16-31(26-28)44-32-17-11-15-30(27-32)43-40-24-25-41-43;;;;/h3-30H,1-2H3;1-27H;1-26H;1-25H;;;;/q4*-2;4*+2
• InChIKey: JZXDLBPJPZDIKV-UHFFFAOYSA-N
• XLogP: 39.06
• TPSA: 180.68 Ų
• H-Bond Acceptors: 21
• Rotatable Bonds: 25
• Heavy Atoms: 192
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3219.22
LogP ≤ 5	39.06
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	21

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+))?

The IUPAC name of 9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+)) (CID 161134093) is 9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+)).

What is the SMILES notation for 9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+))?

The canonical SMILES for 9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+)) is Cc1cccc(C)c1-c1cc(Oc2[c-]c(C3(c4ccccn4)c4ccccc4N(c4ccccc4)c4ccccc43)ccc2)[c-]c(-n2cccn2)c1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[c-]1c(Oc2[c-]c(C3(c4ccccn4)c4ccccc4N(c4ccccc4)c4ccccc43)ccc2)cccc1-c1nc2ccccc2s1.[c-]1c(Oc2[c-]c(C3(c4ccccn4)c4ccccc4N(c4ccccc4)c4ccccc43)ccc2)cccc1-n1cccn1.[c-]1c(Oc2[c-]c(C3(c4ccccn4)c4ccccc4N(c4ccccc4)c4ccccc43)ccc2)cccc1-n1nccn1.

What is the InChIKey of 9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+))?

The InChIKey is JZXDLBPJPZDIKV-UHFFFAOYSA-N. The full InChI is InChI=1S/C47H34N4O.C43H27N3OS.C39H26N4O.C38H25N5O.4Pt/c1-33-15-12-16-34(2)46(33)35-29-38(50-28-14-27-49-50)32-40(30-35)52-39-20-13-17-36(31-39)47(45-25-10-11-26-48-45)41-21-6-8-23-43(41)51(37-18-4-3-5-19-37)44-24-9-7-22-42(44)47;1-2-16-32(17-3-1)46-38-23-7-4-20-35(38)43(41-26-10-11-27-44-41,36-21-5-8-24-39(36)46)31-15-13-19-34(29-31)47-33-18-12-14-30(28-33)42-45-37-22-6-9-25-40(37)48-42;1-2-14-30(15-3-1)43-36-21-6-4-19-34(36)39(38-23-8-9-24-40-38,35-20-5-7-22-37(35)43)29-13-10-17-32(27-29)44-33-18-11-16-31(28-33)42-26-12-25-41-42;1-2-13-29(14-3-1)42-35-20-6-4-18-33(35)38(37-22-8-9-23-39-37,34-19-5-7-21-36(34)42)28-12-10-16-31(26-28)44-32-17-11-15-30(27-32)43-40-24-25-41-43;;;;/h3-30H,1-2H3;1-27H;1-26H;1-25H;;;;/q4*-2;4*+2.

What are the key properties of 9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+))?

9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+)) has a molecular weight of 3219.22 g/mol, XLogP of 39.06, 25 rotatable bonds, 0 hydrogen bond donors, and 21 hydrogen bond acceptors.

Where does this data come from?

All data for 9-[3-[3-(2,6-dimethylphenyl)-5-pyrazol-1-ylbenzene-6-id-1-yl]oxybenzene-2-id-1-yl]-10-phenyl-9-pyridin-2-ylacridine;10-phenyl-9-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-9-pyridin-2-ylacridine;2-[3-[3-(10-phenyl-9-pyridin-2-ylacridin-9-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3-benzothiazole;10-phenyl-9-pyridin-2-yl-9-[3-[3-(triazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]acridine;tetrakis(platinum(2+)) is sourced from PubChem (CID 161134093), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).